BIO-RAD LABORATORIES LIMITED
Get an alert when BIO-RAD LABORATORIES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-13 (in 2mo)
Last made up 2025-06-29
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£18M
-41.9% vs 2023
Employees
95
+2.2% vs 2023
Profit before tax
£2M
-44.9% vs 2023
Name history
Renamed 2 times since incorporation
- BIO-RAD LABORATORIES LIMITED 1995-12-31 → present
- BIO-RAD LIMITED 1995-11-21 → 1995-12-31
- LUDGATE 104 LIMITED 1995-04-11 → 1995-11-21
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £47,237,000 | £46,040,000 | |
| Operating profit | £2,564,000 | £923,000 | |
| Profit before tax | £3,637,000 | £2,003,000 | |
| Net profit | £2,419,000 | £1,532,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £32,588,000 | £18,576,000 | |
| Net assets | £30,527,000 | £17,747,000 | |
| Equity | £30,527,000 | £17,747,000 | |
| Average employees | 93 | 95 | |
| Wages | £6,250,000 | £5,745,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 5.4% | 2.0% | |
| Net margin | 5.1% | 3.3% | |
| Return on capital employed | 7.9% | 5.0% | |
| Current ratio | 4.35x | 2.40x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Consequently, the directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.”
Significant events
- “During the fiscal year 2024, the Life Science Group (LSG) faced significant challenges, resulting in a 17% decline in revenues compared to the previous year. This decrease was primarily driven by underperformance in several key divisions, including Protein Quantitation (PQB), Process Chromatography (PCB), and Droplet Digital PCR (ddPCR).”
- “In contrast, the Clinical Diagnostic Group (CDG) delivered a solid performance in fiscal year 2024, achieving a 12% increase in revenue compared to FY2023. The business began to recover in FY2024, driven by a rise in hospital orders.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| TAYLOR WESSING SECRETARIES LIMITED | Corporate Secretary | 2017-05-31 | — | — |
| CHOPRA, Rajinder Kumar | Director | 2021-02-24 | Oct 1966 | British |
| SCHWARTZ, Norman David | Director | 2001-11-26 | Mar 1950 | American |
| TWEET, Jennifer Marie | Director | 2019-08-26 | Jul 1971 | American |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BURNS, Peter Alfred | Secretary | 1995-11-09 | 2010-08-19 |
| GORDON, Anthony Richard Francis | Nominee Secretary | 1995-04-11 | 1995-11-09 |
| LAWRENCE, Samantha Jane | Secretary | 2010-08-20 | 2017-05-31 |
| WALTER, David Andrew | Nominee Secretary | 1995-04-11 | 1995-11-09 |
| AUDLEY, Maxwell Charles | Nominee Director | 1995-04-11 | 1995-11-09 |
| FORRESTER, David William | Director | 1995-11-09 | 2013-02-28 |
| GORDON, Anthony Richard Francis | Nominee Director | 1995-04-11 | 1995-11-09 |
| HOWARD, Philip | Director | 2013-08-08 | 2021-02-11 |
| REW, Christopher | Director | 2001-11-26 | 2007-09-28 |
| SCHWARTZ, David | Director | 1995-11-09 | 2012-04-27 |
| WALTER, David Andrew | Nominee Director | 1995-04-11 | 1995-11-09 |
| ZABIN, Burton Alan, Dr | Director | 1995-11-09 | 2001-11-26 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Bio-Metrics (U.K.) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 134 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-23 | AA | accounts | Accounts with accounts type full | |
| 2025-07-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-13 | CH01 | officers | Change person director company with change date | |
| 2025-02-21 | CH01 | officers | Change person director company with change date | |
| 2024-12-12 | AA | accounts | Accounts with accounts type full | |
| 2024-08-28 | CH01 | officers | Change person director company with change date | |
| 2024-07-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-11-14 | AA | accounts | Accounts with accounts type full | |
| 2023-06-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-07 | AA | accounts | Accounts with accounts type full | |
| 2022-06-29 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-04-01 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-04-01 | AD01 | address | Change registered office address company with date old address new address | |
| 2021-12-15 | AA | accounts | Accounts with accounts type full | |
| 2021-07-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-02-25 | AP01 | officers | Appoint person director company with name date | |
| 2021-02-15 | TM01 | officers | Termination director company with name termination date | |
| 2020-12-22 | AA | accounts | Accounts with accounts type full | |
| 2020-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-01-11 | DISS40 | gazette | Gazette filings brought up to date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-2.5%
£47,237,000 £46,040,000
-
Cash
—
Not reported
-
Net assets
-41.9%
£30,527,000 £17,747,000
-
Employees
+2.2%
93 95
-
Operating profit
-64%
£2,564,000 £923,000
-
Profit before tax
-44.9%
£3,637,000 £2,003,000
-
Wages
-8.1%
£6,250,000 £5,745,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers